Characterisation of Pasteurella multocida isolates from pigs with pneumonia in Korea

Abstract

Background Pasteurella multocida is responsible for significant economic losses in pigs worldwide. In clinically diseased pigs, most P. multocida isolates are characterised as subspecies multocida , biovar 2 or 3 and capsular type A or D; however, there is little information regarding subspecies, biovars, and other capsular types of P. multocida isolates in Korea. Here, we provided information covering an extended time period regarding P. multocida in pigs with pneumonia in Korea using phenotypic and genotypic characterisations and data associated with the minimum inhibitory concentrations. Results The overall prevalence of P. multocida between 2008 and 2016 was 16.8% (240/1430), with 85% of the P. multocida isolates (204/240) coinfected with other respiratory pathogens. Of the 240 isolates, 166 were included in this study; all of these P. multocida isolates were characterised as subspecies multocida and the most prevalent phenotypes were represented by biovar 3 (68.7%; n = 114) and capsular type A (69.9%; n = 116). Additionally, three capsular type F isolates were identified, with this representing the first report of such isolates in Korea. All biovar 1 and 2 isolates were capsular types F and A, respectively. The virulence-associated gene distribution was variable; all capsular type A and D isolates harboured pmHAS and hsf-1 , respectively ( P < 0.001), with type F (biovar 1) significantly correlated with hsf-1 ( P < 0.05) and pfhA ( P < 0.01), biovar 2 highly associated with pfhA and pmHAS , and biovar 3 significantly correlated with hsf-1 , pmHAS , and hgbB ( P < 0.001), whereas biovar 13 was related only to hgbB ( P < 0.05). The highest resistance rate was found to be to oxytetracycline (63.3%), followed by florfenicol (16.3%). Conclusions P. multocida subspecies multocida , biovar 3, and capsular type A was the most prevalent isolate in this study, and our findings indicated the emergence of capsular type F in Korea. Moreover, prudent use of oxytetracycline and florfenicol is required because of the identified high resistance rates. Further studies are required for continuous monitoring of the antimicrobial resistance, prevalence, and epidemiological characterisation of P. multocida , a...

Phenotypic and Molecular Characterization of the Capsular Serotypes of Pasteurella multocida Isolates from Pneumonic Cases of Cattle in Ethiopia

“…Con rmed P. multocida isolates were assigned into subspecies based on sorbitol and dulcitol fermentation (Mutters et al, 1985;kim et al, 2019). Isolates were further classi ed into their respective biovars based on carbohydrate/sugar fermentation pro les including glucose, lactose, sorbitol, mannitol, trehalose, maltose, xylose, and arabinose) and ornithin decarboxylase (ODC) (Blackall et al, 1997;kim et al, 2019).…”

Phenotypic and Molecular Characterization of the Capsular Serotypes of Pasteurella Multocida Isolates From Bovine Respiratory Disease Cases in Ethiopia

“…Con rmed P. multocida isolates were assigned into subspecies based on sorbitol and dulcitol fermentation [29,30]. Isolates were further classi ed into their respective biovars based on carbohydrate/sugar fermentation pro les including Glucose, lactose, sorbitol, mannitol, trehalose, maltose, xylose, and arabinose) and ornithin decarboxylase (ODC) [31,30].…”

Immune Protective Efficacy of China’s Traditional Inactivated and Attenuated Vaccines against the Prevalent Strains of Pasteurella multocida in Mice

“…P. multocida is a widespread pathogen capable of infecting a wide variety of animals [2][3][4] and an opportunistic pathogen of humans. It is the primary causative agent of fowl cholera in chickens [5], hemorrhagic septicemia in ungulates, snuffles in rabbits [6], and progressive atrophic rhinitis or pneumonia in pigs [7]. Human infection with P. multocida typically occurs after the bites of cats or dogs, and can cause soft tissue infections and pulmonary disease [8][9][10].…”